This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Ucbbiopharma Srl, Five Prime Therapeutics, Inc.. Active years: 2021-2025.
Location History:
- Slough, GB (2021 - 2023)
- Berkshire, GB (2024)
Company Filing History:
4 out of 129 
1 out of 77 
Years Active: 2021-2025
Title: Breda Twomey: Innovator in Medical Research
Introduction
Breda Twomey is a notable inventor based in Slough, GB. She has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. With a total of 4 patents to her name, her work has the potential to impact various therapeutic approaches.
Latest Patents
Among her latest patents is the "GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY." This invention focuses on the medical use of interferon-lambda for the treatment of fibrosis. The research demonstrates that interferon-lambda has directly acting anti-fibrotic effects both in vitro and in vivo, providing effective new therapies for multiple types of fibrosis.
Career Highlights
Breda has worked with several prominent companies in the pharmaceutical industry, including UCB Biopharma and Five Prime Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate on groundbreaking research and development projects.
Collaborations
Throughout her career, Breda has collaborated with talented individuals such as Neesha Dedi and Michael John Wright. These partnerships have contributed to her innovative work and advancements in medical treatments.
Conclusion
Breda Twomey is a pioneering inventor whose research in fibrosis treatment showcases her dedication to improving medical therapies. Her contributions continue to influence the field and inspire future innovations.